-
Product Insights
HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
HIV Point of Care (POC) Pipeline Market Report Overview Point of Care Testing (POC) is typically performed by non-laboratory personnel outside the clinical laboratory close to where the patient is receiving care. The results obtained from such tests are used for clinical decision-making. The HIV Point of Care (POC) pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LACTIN-V in Urinary Tract Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LACTIN-V in Urinary Tract Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LACTIN-V in Urinary Tract Infections Drug Details: LACTIN-V is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CFI-400945 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CFI-400945 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.CFI-400945 in Solid Tumor Drug Details:CFI-400945 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LACTIN-V in Premature Labor (Tocolysis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LACTIN-V in Premature Labor (Tocolysis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.LACTIN-V in Premature Labor (Tocolysis) Drug Details:LACTIN-V is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – LACTIN-V
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry LACTIN-V Drug Details LACTIN-V is under development for the prevention and treatment of recurrent...
-
Report Bundle
50% offInnovations in Pharma – Report Bundle (5 Reports)
Innovations in Pharma Bundle Report Overview The healthcare industry constantly demands innovation, improvement, accessibility, and affordability. The ‘Innovations in Pharma’ bundle highlights the emerging drug development technologies in providing quality healthcare services. Accessing the in-depth insight from the Innovations in Pharma bundle can help you: Make informed decisions about investments, partnerships, and product development Understand your competitors’ strengths and weaknesses, identify areas of opportunity, and develop strategies to stay ahead in the market Anticipate market changes and adjust your strategies accordingly...
-
Product Insights
Glycoprotein 41 (gp41) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Glycoprotein 41 pipeline drugs market research report outlays comprehensive information on the Glycoprotein 41 (gp41) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players involved in Glycoprotein 41 (gp41) targeted therapeutics development with respective active and dormant or discontinued projects.
-
Sector Analysis
Contract Injectable Packaging Trends in the Bio/Pharma Industry
Injectables and their packaging requirements are very important to marketed treatments given the volume of vaccines required to tackle the COVID-19 pandemic and the rising number of biologics in development pipelines and on the market. Most injectable drugs in the development pipeline are biologics, which will become increasingly approved and more established in the treatment landscape in the future. The top contract packaging organizations (CPOs) for injectables by the number of contracts are standalone packagers along with large CMOs which...
-
Thematic Analysis
Microbiome-Targeting Therapeutics in Infectious Diseases – Thematic Research
Microbiome is the community of microorganisms such as fungi, bacteria, and viruses, and their genetic material existing in and on the human body. Although the primary site of aggregated microbes is in the gastrointestinal (GI) tract, populations of microorganisms are also found on the surface of the skin, in the upper and lower respiratory tract, and in the genitourinary tracts. Microbiome-targeting drugs aim to alter the microbial composition of the gut through the administration of live microbes (probiotics), or other...
-
Product Insights
Premature Labor (Tocolysis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Premature labor pipeline market research report provides a comprehensive overview on the therapeutics under development for Premature labor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Premature labor and features...